ES443846A1 - Un procedimiento para la preparacion de 1-r-3-pirolidinil- alfa, alfa-difenilacetamidas, -acetonitrilos y -metanos. - Google Patents
Un procedimiento para la preparacion de 1-r-3-pirolidinil- alfa, alfa-difenilacetamidas, -acetonitrilos y -metanos.Info
- Publication number
- ES443846A1 ES443846A1 ES443846A ES443846A ES443846A1 ES 443846 A1 ES443846 A1 ES 443846A1 ES 443846 A ES443846 A ES 443846A ES 443846 A ES443846 A ES 443846A ES 443846 A1 ES443846 A1 ES 443846A1
- Authority
- ES
- Spain
- Prior art keywords
- antiarrhythmia
- methods
- alpha
- represents hydrogen
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000003288 anthiarrhythmic effect Effects 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000006518 morpholino carbonyl group Chemical group [H]C1([H])OC([H])([H])C([H])([H])N(C(*)=O)C1([H])[H] 0.000 abstract 1
- -1 pyrrolidinocarbonyl Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/536,708 US4002766A (en) | 1974-12-26 | 1974-12-26 | Antiarrhythmia methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES443846A1 true ES443846A1 (es) | 1977-07-16 |
Family
ID=24139598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES443846A Expired ES443846A1 (es) | 1974-12-26 | 1975-12-24 | Un procedimiento para la preparacion de 1-r-3-pirolidinil- alfa, alfa-difenilacetamidas, -acetonitrilos y -metanos. |
Country Status (18)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4133881A (en) * | 1977-04-27 | 1979-01-09 | A. H. Robins Company, Incorporated | Azetidinyl acetonitrile and acetamide antiarrhythmia compositions and methods |
| US4242261A (en) * | 1979-07-19 | 1980-12-30 | A. H. Robins Company, Inc. | Production of methylene-cycloamines |
| US4260606A (en) * | 1979-07-19 | 1981-04-07 | A. H. Robins Company, Inc. | 3-Methyleneazetidine derivatives |
| US4812452A (en) * | 1984-10-19 | 1989-03-14 | A. H. Robins Company, Incorporated | 1-((aminoalkyl and aminoalkylamino) carbonyl and thiocarbonyl)-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles |
| US4812451A (en) * | 1984-10-19 | 1989-03-14 | A. H. Robins Company, Incorporated | 1-(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-α,.alpha. |
| US4594343A (en) * | 1984-10-19 | 1986-06-10 | Shanklin Jr James R | 1-[(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl]-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles |
| IL76583A (en) * | 1984-10-19 | 1988-08-31 | Robins Co Inc A H | 1-(aminoalkyl)-alpha'alpha-diaryl pyrrolidinyl,piperidino and homopiperidino acetamides and acetonitriles and pharmaceutical compositions containing them |
| US4810703A (en) * | 1984-10-19 | 1989-03-07 | A. H. Robins Company, Incorporated | 1-((aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-alpha, alpha-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles |
| GB8825505D0 (en) * | 1988-11-01 | 1988-12-07 | Pfizer Ltd | Therapeutic agents |
| US5932594A (en) * | 1988-11-01 | 1999-08-03 | Pfizer, Inc. | Muscarinic receptor antagonists |
| US5233053A (en) * | 1989-03-17 | 1993-08-03 | Pfizer Inc. | Pyrrolidine derivatives |
| GB8906166D0 (en) * | 1989-03-17 | 1989-05-04 | Pfizer Ltd | Therapeutic agents |
| US6693202B1 (en) | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
| TW200800953A (en) * | 2002-10-30 | 2008-01-01 | Theravance Inc | Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine |
| US7317102B2 (en) * | 2003-04-01 | 2008-01-08 | Theravance, Inc. | Diarylmethyl and related compounds |
| TW200510298A (en) * | 2003-06-13 | 2005-03-16 | Theravance Inc | Substituted pyrrolidine and related compounds |
| EP1644356A1 (en) * | 2003-07-11 | 2006-04-12 | Theravance, Inc. | Substituted 4-amino-1-benzylpiperidine compounds |
| US7250414B2 (en) * | 2004-03-11 | 2007-07-31 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
| US7071224B2 (en) * | 2004-03-11 | 2006-07-04 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
| TW200540154A (en) * | 2004-06-10 | 2005-12-16 | Theravance Inc | Crystalline form of a substituted pyrrolidine compound |
| EP1891034A2 (en) * | 2005-12-27 | 2008-02-27 | Teva Pharmaceutical Fine Chemicals S.R.L. | Processes for preparing darifenacin hydrobromide |
| BRPI0807615A8 (pt) * | 2007-02-23 | 2017-12-05 | Theravance Inc | Compostos de difenilmetil amônico quaternário úteis como antagonistas de receptor muscarínico |
| ES2425592T3 (es) * | 2007-04-24 | 2013-10-16 | Theravance, Inc. | Compuestos de amonio cuaternario de utilidad como antagonistas de los receptores muscarínicos |
| WO2012166909A1 (en) * | 2011-06-03 | 2012-12-06 | Galleon Pharmaceuticals, Inc. | Compositions and methods for treating breathing control disorders or diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3192210A (en) * | 1961-12-04 | 1965-06-29 | Robins Co Inc A H | 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-pyrrolidinones and 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-thionpyrrolidinones |
| NL6606516A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1965-05-17 | 1966-11-18 | ||
| US3878217A (en) * | 1972-01-28 | 1975-04-15 | Richardson Merrell Inc | Alpha-aryl-4-substituted piperidinoalkanol derivatives |
-
1974
- 1974-12-26 US US05/536,708 patent/US4002766A/en not_active Expired - Lifetime
-
1975
- 1975-12-15 AU AU87549/75A patent/AU498763B2/en not_active Expired
- 1975-12-18 SE SE7514375A patent/SE428126B/xx not_active IP Right Cessation
- 1975-12-19 FI FI753607A patent/FI753607A7/fi not_active Application Discontinuation
- 1975-12-22 CH CH1660475A patent/CH619932A5/fr not_active IP Right Cessation
- 1975-12-22 BE BE163037A patent/BE836974A/xx not_active IP Right Cessation
- 1975-12-23 FR FR7539571A patent/FR2295745A1/fr active Granted
- 1975-12-23 DK DK589175AA patent/DK137751B/da not_active IP Right Cessation
- 1975-12-23 ZA ZA00757974A patent/ZA757974B/xx unknown
- 1975-12-23 GB GB52610/75A patent/GB1535770A/en not_active Expired
- 1975-12-23 IE IE2823/75A patent/IE43901B1/en unknown
- 1975-12-23 NO NO754377A patent/NO754377L/no unknown
- 1975-12-23 CA CA242,431A patent/CA1055396A/en not_active Expired
- 1975-12-24 DE DE19752558501 patent/DE2558501A1/de active Granted
- 1975-12-24 NL NLAANVRAGE7515071,A patent/NL185620C/xx not_active IP Right Cessation
- 1975-12-24 ES ES443846A patent/ES443846A1/es not_active Expired
- 1975-12-24 PH PH17925A patent/PH13483A/en unknown
- 1975-12-26 JP JP50159798A patent/JPS5191255A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES443846A1 (es) | Un procedimiento para la preparacion de 1-r-3-pirolidinil- alfa, alfa-difenilacetamidas, -acetonitrilos y -metanos. | |
| GB1110520A (en) | Arylacetic acid amides | |
| GB1394416A (en) | Cyclopropanecarboxylates processes for producing them and compositions containing them | |
| IE41440L (en) | Thiatetracyclines | |
| ES443845A1 (es) | Un procedimiento para la preparacion de n-(1-sustituido-3- pirrolidinil)-1-naftalen y 4-quinoleincarboxamidas. | |
| GB1018985A (en) | Benzoxacycloalkanemethylamines | |
| IE40661B1 (en) | Novel tetracyclic piperidino derivatives | |
| ES470296A1 (es) | Mejoras introducidas en un procedimiento para la preparacionde fluormetal-aminoacidos | |
| GB1482099A (en) | Sulphonamido derivatives | |
| ES450897A1 (es) | Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-noroximorfona. | |
| ES432027A1 (es) | Un procedimiento para la preparacion de anilinobenzotiazo- les. | |
| GB1519210A (en) | Antiarrythmic compositions containing pyrrolidinyl derivatives | |
| ES449068A1 (es) | Procedimiento para preparar derivados de isoxazol. | |
| ES8204980A1 (es) | Procedimietno para la preparacion de salicilato de lidocaina monohidrato. | |
| GB1296802A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| GB1341155A (en) | Dithiophosphoric acid esters having insecticidal acaricidal and nematocidal properties | |
| ES468486A1 (es) | Procedimiento para la preparacion de nuevos derivados de 1-(3-(3,4,5-trimetoxifenoxi)-2-hidroxi - propil)-4-aril pi- perazina | |
| GB1343833A (en) | Substituted hexahydroazepines | |
| IE41106B1 (en) | Pharmaceutical compositions containing benzylamines | |
| GB1431279A (en) | Thiazole derivatives and their use as cardiovascular agents | |
| GB1394184A (en) | 4,5-dihydropyridazine-3 2h- ones | |
| GB1437788A (en) | Therapeutic compositions | |
| GB1334296A (en) | 3-aryloxy-8-carbamoylnortropanes | |
| GB1493100A (en) | Herbicides | |
| GB1294053A (en) | Phosphoric acid esters and their use as insecticides, acaricides and nematocides |